Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Nuveen Select Maturities Municipal Fund | NIM | Jan 15, 2025 | 8.89 | +0.68 |
Nuveen Select Tax Free Income Portfolio | NXP | Jan 15, 2025 | 14.82 | +0.27 |
Nuveen Taxable Municipal Fund | NBB | Jan 15, 2025 | 15.33 | +0.20 |
Nuveen Variable Rate Pref Fund | NPFD | Jan 15, 2025 | 18.69 | -0.64 |
Nuveen Virginia Quality Municipal Income Fund | NPV | Jan 15, 2025 | 12.54 | -0.95 |
Nuvve | NVVE | Jan 15, 2025 | 2.73 | +5.41 |
Nuwellis | NUWE | Jan 15, 2025 | 1.07 | +1.90 |
NV5 Global | NVEE | Jan 15, 2025 | 18.09 | +0.44 |
NVE | NVEC | Jan 15, 2025 | 81.64 | +2.01 |
nVent Electric | NVT | Jan 15, 2025 | 70.28 | +0.49 |
NVIDIA | NVDA | Jan 15, 2025 | 136.24 | +3.40 |
Nvni Group | NVNI | Jan 15, 2025 | 1.69 | +16.15 |
NVR | NVR | Jan 15, 2025 | 8 259.08 | +1.42 |
NWTN B | NWTN | Jan 15, 2025 | 0.74 | +6.00 |
NXG NextGen Infrastructure Income Fund | NXG | Jan 15, 2025 | 50.11 | +2.16 |
NXP Semiconductors | NXPI | Jan 15, 2025 | 213.56 | +1.39 |
Nxu | NXU | Jan 15, 2025 | 0.56 | -8.13 |
NYLI CBRE Global Infrastructure Megatrends Term Fund | MEGI | Jan 15, 2025 | 12.35 | +1.90 |
NYSE Arca Biotech Index First Trust | FBT | Jan 15, 2025 | 173.55 | +0.41 |
Nyse Composite | NYA | Jan 15, 2025 | 19 456.00 | +1.71 |
Nyxoah SA | NYXH | Jan 15, 2025 | 10.05 | +7.83 |
O-I Glass | OI | Jan 15, 2025 | 10.45 | +0.29 |
Oak Valley Bancorp | OVLY | Jan 15, 2025 | 26.48 | -3.81 |
Oak Woods Acquisition | OAKU | Jan 15, 2025 | 11.39 | +0.09 |
Oaktree Acquisition III Life Sciences | OACC | Jan 15, 2025 | 9.97 | 0.00 |
Oaktree Acquisition III Life Sciences Unit | OACCU | Jan 15, 2025 | 10.19 | 0.00 |
Oaktree Capital A Pref | OAK-A | Jan 15, 2025 | 22.72 | +1.00 |
Oaktree Capital Group B Pref | OAK-B | Jan 15, 2025 | 21.90 | +1.20 |
Oaktree Specialty | OCSL | Jan 15, 2025 | 15.44 | +1.11 |
Oatly ADR | OTLY | Jan 15, 2025 | 0.66 | +1.02 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.